Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Ascendis Pharma A (ASND) over the last 6 years, with Q4 2025 value amounting to 0.16%.

  • Ascendis Pharma A's Return on Invested Capital rose 2500.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.16%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.18% for FY2025, which is 2600.0% up from last year.
  • Ascendis Pharma A's Return on Invested Capital amounted to 0.16% in Q4 2025, which was up 2500.0% from 0.19% recorded in Q3 2025.
  • Ascendis Pharma A's Return on Invested Capital's 5-year high stood at 0.16% during Q4 2025, with a 5-year trough of 3.48% in Q2 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.54% (2021), whereas its average is 0.82%.
  • Per our database at Business Quant, Ascendis Pharma A's Return on Invested Capital plummeted by -28400bps in 2023 and then surged by 28100bps in 2024.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Return on Invested Capital stood at 0.46% in 2021, then crashed by -83bps to 0.85% in 2022, then crashed by -34bps to 1.14% in 2023, then soared by 64bps to 0.41% in 2024, then soared by 61bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q4 2025, 0.19% for Q3 2025, and 0.36% during Q2 2025.